Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04186039
Other study ID # APHP191058
Secondary ID 2019-A02623-54
Status Withdrawn
Phase N/A
First received
Last updated
Start date May 2020
Est. completion date May 2022

Study information

Verified date November 2022
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective is to evaluate the quality of the response to the Blood Oxygen Level Dependent effect in fetuses with diaphragmatic hernias and abdominal wall malformations and to correlate with postnatal respiratory outcome. Pulmonary involvement is a constant in diaphragmatic hernias, it is classic in omphaloceles and especially hepatomphaloceles, and exceptional in laparoschisis. As this is an original exploratory study, no preliminary data are available. If a correlation is found, the Blood Oxygen Level Dependent effect of the fetal lung may be considered as an early functional marker of postnatal lung function. It can be used in addition to lung-to-head-ratio during prenatal counseling. The final goal is to be able to detect early in the fetus pulmonary insufficiency to help prenatal counseling and perinatal care.


Description:

During the fetal period, there is in the lungs a permanent flow and pressure variations between the "inhaled" amniotic fluid and alveolar secretions, which are essential for pulmonary development. A disruption of this physiological mechanism can induce disorders of the respiratory function, which go from simple delay of maturation to hypoplasia. Respiratory function involves the thoracic muscles (diaphragmatic and intercostal) but also the abdominal muscles, that explains why breathing difficulties are found at birth in neonates with diaphragmatic hernia but also abdominal wall malformations. This pulmonary involvement highly contributes to the morbidity observed at birth, for which strong prenatal predictive criteria are lacking. Pulmonary volume measurement by the lung-to-head-ratio is widely used for diaphragmatic hernia has been extended to other congenital malformations, because no other available criteria. The lung-to-head-ratio is a parameter well correlated with survival but insufficiently with morbidity and sequelae. New functional imaging techniques are in development. Among them, the Blood Oxygen Level Dependent uses hemoglobin as an endogenous contrast agent. It is based on the comparison of a basic status in ambient air with status after oxygenation. It gives a functional evaluation of the organs. But this technique has never been evaluated in the fetal lung yet. The objective of the study is to evaluate the quality of the response to the Blood Oxygen Level Dependent effect in fetuses with diaphragmatic hernias and abdominal wall malformations and to correlate with postnatal respiratory outcome. It is an original exploratory study and no preliminary data are thus available. If a correlation is found, the Blood Oxygen Level Dependent effect of the fetal lung may be considered as an early functional marker of postnatal lung function. It could then be used in addition to lung-to-head-ratio during prenatal counseling. The final goal is to be able to detect early in the fetus pulmonary insufficiency to help prenatal counseling and perinatal care.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 2022
Est. primary completion date May 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Major patient, - patient with a simple pregnancy, - patient between 28 and 33 weeks of amenorrhea, - patient undergoing fetal MRI as part of their usual care, for fetal / placental indications : diaphragmatic hernia, omphalocele and laparoschisis, - informed consent signed by the patient and the investigator, - patient affiliated to a social security scheme (beneficiary or beneficiary). Exclusion Criteria: - Patient with one of the usual contraindications for MRI, - claustrophobic patient, - patient with an abdominal perimeter> 125 cm, - patient with multiple-birth pregnancy, - patient with a pregnancy at the end of a long course of medical assisted procreation, - patient with chronic respiratory disease.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Functional magnetic resonance imaging - Blood Oxygenation Level Dependent
First Functional magnetic resonance imaging - Blood Oxygenation Level Dependent sequence under ambient air. Oxygenation of 5 minutes at a rate of 12 l / min. Second Functional magnetic resonance imaging - Blood Oxygenation Level Dependent sequence.

Locations

Country Name City State
France Hôpital Necker-Enfants Malades Paris

Sponsors (2)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Filière des Maladies Rares Abdomino-THOraciques : FIMATHO

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Value of the Blood Oxygenation Level Dependent of the fetal lung Regions of interest (ROI) were manually identified on MRI images, with the largest possible homogenous 2D area. For the lungs, the ROIs were delineated at the maximal chest circumference, delineating the right lung, the left lung.
Changes in haemoglobin concentration will be evaluated by the variation in transverse R2* signal induced by oxygenation in the delimited ROI.
The BOLD response will be calculated for each case as the difference between normoxic and hyperoxic period (?R2*) normalized by normoxic value: ?R2* = [R2*(norm)-R2*(hyper)] / R2*(norm).
30 months
Primary Postnatal respiratory evolution Duration of mechanical ventilation 30 months
Secondary Postnatal survival Survival rate at 30 days after birth 30 months
Secondary Duration of oxygen dependence Total days of oxygen requiring 30 months
Secondary Length of hospitalization Total days of the neonatal hospitalization before discharge 30 months
See also
  Status Clinical Trial Phase
Recruiting NCT05100693 - Smart Removal for Congenital Diaphragmatic Hernia N/A
Recruiting NCT05450653 - Trial of FETO for Severe Congenital Diaphragmatic Hernia N/A
Terminated NCT04140669 - Automated Myocardial Performance Index Using Samsung HERA W10
Recruiting NCT05201144 - A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH) Phase 2
Recruiting NCT04429750 - Intact Cord Resuscitation in CDH N/A
Recruiting NCT03750266 - 3D Animation and Models to Aid Management of Fetal CDH
Completed NCT01243229 - Genetic Analysis of Congenital Diaphragmatic Disorders
Recruiting NCT04583644 - Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH) N/A
Completed NCT03314233 - Delayed Cord Clamping for Congenital Diaphragmatic Hernia N/A
Recruiting NCT04114578 - Exploratory Observational Prospective Study in Neonatal and Pediatric Congenital Diaphragmatic Hernia
Completed NCT03666767 - Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
Recruiting NCT02986087 - Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia N/A
Recruiting NCT03674372 - Fetoscopic Endoluminal Tracheal Occlusion N/A
Active, not recruiting NCT05839340 - Neurally Adjusted Ventilatory Assist for Neonates With Congenital Diaphragmatic Hernias N/A
Enrolling by invitation NCT05962346 - Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia N/A
Unknown status NCT01302977 - Fetal Tracheal Occlusion in Severe Diaphragmatic Hernia: a Randomized Trial Phase 2
Recruiting NCT03179371 - Proteomic Profiling for Congenital Diaphragmatic Hernia
Not yet recruiting NCT03138863 - Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO) N/A
Active, not recruiting NCT04484441 - Maternal-fetal Immune Responses to Fetal Surgery
Completed NCT03787160 - Microbiome and Volatile Organic Compounds in Patients With CDH N/A